- Home
- IDN vs PLRX Comparison
IDN vs PLRX Comparison
Compare IDN & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDN
- PLRX
- Stock Information
- Founded
- IDN 1994
- PLRX 2015
- Country
- IDN United States
- PLRX United States
- Employees
- IDN N/A
- PLRX N/A
- Industry
- IDN Computer Software: Prepackaged Software
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- IDN Technology
- PLRX Health Care
- Exchange
- IDN Nasdaq
- PLRX Nasdaq
- Market Cap
- IDN 101.6M
- PLRX 93.3M
- IPO Year
- IDN 1999
- PLRX 2020
- Fundamental
- Price
- IDN $4.58
- PLRX $1.77
- Analyst Decision
- IDN Strong Buy
- PLRX Hold
- Analyst Count
- IDN 3
- PLRX 11
- Target Price
- IDN $6.17
- PLRX $3.79
- AVG Volume (30 Days)
- IDN 97.1K
- PLRX 936.5K
- Earning Date
- IDN 11-12-2025
- PLRX 11-06-2025
- Dividend Yield
- IDN N/A
- PLRX N/A
- EPS Growth
- IDN N/A
- PLRX N/A
- EPS
- IDN N/A
- PLRX N/A
- Revenue
- IDN $20,662,000.00
- PLRX N/A
- Revenue This Year
- IDN $9.73
- PLRX N/A
- Revenue Next Year
- IDN $11.75
- PLRX N/A
- P/E Ratio
- IDN N/A
- PLRX N/A
- Revenue Growth
- IDN 7.12
- PLRX N/A
- 52 Week Low
- IDN $2.17
- PLRX $1.10
- 52 Week High
- IDN $6.49
- PLRX $15.85
- Technical
- Relative Strength Index (RSI)
- IDN 42.27
- PLRX 58.32
- Support Level
- IDN $4.36
- PLRX $1.45
- Resistance Level
- IDN $4.60
- PLRX $1.72
- Average True Range (ATR)
- IDN 0.21
- PLRX 0.12
- MACD
- IDN 0.01
- PLRX -0.01
- Stochastic Oscillator
- IDN 51.19
- PLRX 62.50
About IDN Intellicheck Inc.
Intellicheck Inc is a trusted industry leader in technology solutions that stop identity theft and fraud with real-time identification authentication and age verification. The group delivers on-demand digital and physical identity verification solutions for KYC, AML, fraud prevention, and age verification needs. The products of the company include solutions for preventing identity fraud across any industry delivered via smartphone, tablet, POS integration or other electronic devices.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.